Oscar Health Inc. (OSCR) Tops Q4 EPS by 6c; offers guidance

Oscar Health Inc. (NYSE: OSCR) reported Q4 EPS of ($0.66), $0.06 better than the analyst estimate of ($0.72). Revenue for the quarter came in at $1.43 billion versus the consensus estimate of $1.43 billion.

GUIDANCE:

Oscar Health Inc. sees FY2024 revenue of $8.3-8.4 billion, versus the consensus of $7.265 billion.

For earnings history and earnings-related data on Oscar Health Inc. (OSCR) click here.

You May Also Be Interested In

• Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
• RBC Capital Starts Tabcorp Holdings (TAH:AU) (TABCF) at Outperform
• CMS targets 15% Medicare lab fee cuts, putting DGX and LH revenue at risk